InVivo Therapeutics Holdings Corporation
$0.37▲ 12.12%(+$0.04)
MKT CAP $1.15MLAST EARNINGS Aug 7, 2024
50%
Bullish
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
100
Valuation
20
Profitability
84
Health
30
Momentum
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NVIVQ research report →
Price Chart
-72.59% · this period
52-Week Range17% of range
Low
$0.15
Current
$0.37
High
$1.41
Company Overviewwww.invivotherapeutics.com
About the company
InVivo Therapeutics Holdings Corp. is a U. S.
- CEO
- Richard M. Toselli
- IPO
- 2010
- Employees
- 6
- HQ
- Cambridge, MA, US
Get TickerSpark's AI analysis on NVIVQ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Internal Compare
Similar companies
Peers in the same neighborhood.
Valuation
- Market Cap
- $1.15M
- P/E
- -0.05
- PEG
- -0.00
- P/S
- 0.00
- P/B
- 0.03
- EV/EBITDA
- 1.46
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -60.12%
- ROIC
- -63.58%
Performance & Tape
- 52W High
- $1.41
- 52W Low
- $0.15
- 50D MA
- $0.38
- 200D MA
- $0.56
- Beta
- 0.37
- RSI (14)
- 49
- Avg Volume
- 8.13K
No earnings-call transcripts are available for NVIVQ yet.
Float & Shares
- Free Float
- 94.7%
- Shares Outstanding
- 3.11M
- Float Shares
- 2.94M
Coverage · NVIVQ
Our NVIVQ coverage
Recent articles, reports, and earnings notes.
On-Demand Research
No research on NVIVQ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NVIVQ report →